NCT03978793Completed
MyTPill: A Novel Strategy to Monitor Antiretroviral Adherence Among HIV+ Prescription Opioid Users
Source: ClinicalTrials.gov · Last updated 3 Aug 2025
Brief summary (registry, in English)
This study compares several different antiretroviral adherence measures, including digital pills, in HIV+ individuals who are maintained on opioid analgesics.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 31 (actual)
- First submitted
- 4 Jun 2019
- Start date
- 1 Feb 2021
- Primary completion date
- 12 Mar 2025
- Lead sponsor
- Ohio State University
- Diseases
- HIV
- NCT number
- NCT03978793
What you commit to
- Study type: Observational
- Participants enrolled: 31
- From 1 Feb 2021 to the primary completion date, 12 Mar 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Severe renal or hepatic disease
- History of Crohn's disease or Ulcerative Colitis
- History of bowel surgery, gastric bypass, or bowel stricture
- History of gastrointestinal malignancy or radiation to the abdomen.
Lab values
- Hypersensitivity to silver, magnesium, or zinc following oral use
Other
- Pregnancy
- non-English speaking
Who the study is looking for
- HIV+, Viral load \>200copies/mL, on single pill containing TDF/FTC, receiving prescription for opioid analgesics
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Miami Coordinator of this site? Confirm its status | Miami | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.